Martin Shkreli, the Turing Pharmaceutical chief executive reviled for jacking up drug prices, doesn't want to talk about drug prices anymore.
But he does want to be heard.
The so-called "most hated man in America" wanted to appear Thursday on CNBC to defend rival Valeant Pharmaceuticals against a short-selling firm's report accusing the company of Enron-like accounting fraud. But when producers said they wanted to probe him about drug prices, too, he refused to go on air.
Scott Wapner, the host of CNBC's "Halftime Report," tweeted the story:
Instead, it appears that Shkreli took his interview to Fox Business Network, Fox News' business and finance branch that has struggled to compete with CNBC for viewers.
It remains unclear why his opinion on the subject is worth pursuing. However, it's bound to be entertaining television.